02096.HK
Simcere Pharmaceutical Group Limited
HKSE · Healthcare · Biotechnology · CN
HKD 10.14
−2.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 12.69x
- P/E 2027E
- 10.44x
- P/E 2028E
- 9.11x
- P/S forward
- 4.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.14x
- PEG TTM
- 0.92x
- Price / book
- 2.30x
- Price / sales
- 2.50x
- Price / cash flow
- 7.78x
Enterprise value
- Enterprise value
- HKD 23.7B
- EV / sales
- 2.32x
- EV / EBITDA
- 9.77x
- EV / EBIT
- 11.09x
- Market cap
- HKD 25.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026